The Motley Fool··Thomas NielTilray's Marijuana Rescheduling Rally Fades as Market Sees Through Hype
Tilray stock surged then fell on marijuana rescheduling news. Schedule III change eases taxes but won't unlock U.S. market entry without full legalization.
TLRYcannabis stocksregulatory headwinds